Letters Too much medicine

Direct to consumer unproved screening tests turn a profit in Japan

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4725 (Published 30 July 2013) Cite this as: BMJ 2013;347:f4725
  1. Yasuharu Tokuda, internist1,
  2. Mitchell D Feldman, professor of medicine2
  1. 1University of Tsukuba, 3-2-7 Miya-machi, Mito, Ibaraki, Japan
  2. 2University of California, San Francisco, 1545 Divisadero, Suite 315, San Francisco, CA 94143-0320, USA
  1. yasuharu.tokuda{at}gmail.com

Japanese doctors and patients face much the same problem of too much medicine outlined by Glasziou and colleagues.1 The Japanese healthcare system is rightly lauded as a model of cost containment while achieving better outcomes on many key health indicators than the United States and other developed nations …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe